Zenas BioPharma’s investigational relapsing multiple sclerosis (RMS) asset, obexelimab, has met its primary endpoint in the Phase II MoonStone trial. Image credit: OksanaFedorchuk via Shutterstock.com ...

Held on 29 October 2025 at Faktory Hammerbrooklyn, the conference brings together senior executives and digital leaders from across the DACH region and the UK. The event's rapid sell-out highlights ...

Oct. 24 (UPI) --Three of the all-time biggest R&B acts will team up to participate in a 30-city tour starting early next year: New Edition, Toni Braxton and Boyz II Men. Black Promoters Collective on ...

Metchie, 25, entered the NFL as the No. 44 overall pick in the second round of the 2022 NFL draft. He is scheduled to be a restricted free agent in 2026. Metchie has appeared in 36 games during his ...